Ibafloxacin is a fluoroquinolone antibiotic primarily utilized in veterinary medicine within the European Union to combat bacterial infections. This class of drugs functions by inhibiting bacterial DNA… Read more
Ibafloxacin is a fluoroquinolone antibiotic primarily utilized in veterinary medicine within the European Union to combat bacterial infections. This class of drugs functions by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication. The category encompasses high-quality reference standards for Ibafloxacin API, alongside its identified impurities, potential metabolites, and stable isotope labelled compounds. These materials are critical for pharmaceutical laboratories performing impurity profiling and rigorous analytical method development. By utilizing these precise reference materials, researchers can ensure the accuracy of quality control testing, validate analytical procedures, and maintain compliance with established pharmaceutical standards. These compounds support the comprehensive characterization of the active pharmaceutical ingredient throughout the drug development lifecycle and ongoing stability monitoring.